Abstract: . . .  2,3 ) have been encouraging, suggesting that intracoronary adenoviral vec- tors expressing VEGF or FGF-4 may have therapeutic efficacy. Our results indicate that plasmid gene transfer via directed percutaneous intramyocardial injection could be Figure 3. Segmental ventricular function of the injected area expressed as standard deviations (SD)/cord as assessed from digitized left ventriculog- . . .
. . .  11): Chojnowska, Kukula, Dabrowski, Witkowski, Chmielak, Teresiska; Poland, Krakow (n 10): Rzeszutko, Heba, Hubalewska, Sowa-Staszczak. 988 Kastrup et al. JACC Vol. 45, No. 7, 2005 Intramyocardial VEGF Gene Therapy for Angiogenesis April 5, 2005:9828  . . .
. . .  Intervent Cardiol 2002; 15:713. 14. Freedman SB, Vale P, Kalka C, et al. Plasma vascular endothelial growth factor (VEGF) levels after intramuscular and intramyocardial gene transfer of VEGF-1 plasmid DNA. Hum Gene Ther 2002;13: 1595603. APPENDIX Safety Committee: Jensen, Sweden; Thayssen, Denmark; Klein, Austria. SPECT Core Laboratory: Tgil, Eden- brandt, Sweden; Hesse, . . .
. . .  13. Sylvn C, Sarkar N, Insulander P, et al. Catheter-based transcutaneous transendocardial myocardial gene transfer. J Intervent Cardiol 2002; 15:713. 14. Freedman SB, Vale P, Kalka C, et al. Plasma vascular endothelial growth factor (VEGF) levels after intramuscular and intramyocardial gene transfer of VEGF-1 plasmid DNA. Hum Gene Ther 2002;13: 1595603. APPENDIX Safety Committee: . . .
. . .  C, Sarkar N, Insulander P, et al. Catheter-based transcutaneous transendocardial myocardial gene transfer. J Intervent Cardiol 2002; 15:713. 14. Freedman SB, Vale P, Kalka C, et al. Plasma vascular endothelial growth factor (VEGF) levels after intramuscular and intramyocardial gene transfer of VEGF-1 plasmid DNA. Hum Gene Ther 2002;13: 1595603. APPENDIX Safety Committee: Jensen, . . .
. . .  Insulander P, et al. Catheter-based transcutaneous transendocardial myocardial gene transfer. J Intervent Cardiol 2002; 15:713. 14. Freedman SB, Vale P, Kalka C, et al. Plasma vascular endothelial growth factor (VEGF) levels after intramuscular and intramyocardial gene transfer of VEGF-1 plasmid DNA. Hum Gene Ther 2002;13: 1595603. APPENDIX Safety Committee: Jensen, Sweden; Thayssen, . . .
. . .  P, et al. Catheter-based transcutaneous transendocardial myocardial gene transfer. J Intervent Cardiol 2002; 15:713. 14. Freedman SB, Vale P, Kalka C, et al. Plasma vascular endothelial growth factor (VEGF) levels after intramuscular and intramyocardial gene transfer of VEGF-1 plasmid DNA. Hum Gene Ther 2002;13: 1595603. APPENDIX Safety Committee: Jensen, Sweden; Thayssen, Denmark; . . .
--3000,7,214,3387,40047